Analog Devices, First Quarter, Fiscal 2017 |
||||||||||||||||||
Schedule E |
||||||||||||||||||
Reconciliation from GAAP to Non-GAAP Revenue and Earnings
Measures (In thousands, except per-share amounts)
|
||||||||||||||||||
See "Non-GAAP Financial Information" in this press release for
a description of the items excluded from our non-GAAP
|
||||||||||||||||||
Three Months Ended | ||||||||||||||||||
1Q 17 | 4Q 16 | 1Q 16 | ||||||||||||||||
Jan. 28, | Oct. 29, | Jan. 30, | ||||||||||||||||
2017 | 2016 | 2016 | ||||||||||||||||
GAAP Gross Margin |
$ |
648,504 |
$ |
666,687 |
$ |
477,293 |
||||||||||||
Gross Margin Percentage |
65.9 |
% |
66.4 |
% |
62 |
% |
||||||||||||
Acquisition-Related Expenses | 2,178 | 2,040 | 1,445 | |||||||||||||||
Non-GAAP Gross Margin |
$ |
650,682 |
$ |
668,727 |
$ |
478,738 |
||||||||||||
Gross Margin Percentage |
66.1 |
% |
66.6 |
% |
62.2 |
% |
||||||||||||
GAAP Operating Expenses |
$ |
382,236 |
$ |
309,706 |
$ |
282,248 |
||||||||||||
Percent of Revenue |
38.8 |
% |
30.9 |
% |
36.7 |
% |
||||||||||||
Acquisition-Related Expenses |
(18,232 |
) |
(17,999 |
) |
(17,457 |
) |
||||||||||||
Acquisition-Related Transaction Costs |
(8,011 |
) |
(5,210 |
) |
— | |||||||||||||
Restructuring-Related Expense |
(49,463 |
) |
— | — | ||||||||||||||
Non-GAAP Operating Expenses |
$ |
306,530 |
$ |
286,497 |
$ |
264,791 |
||||||||||||
Percent of Revenue |
31.1 |
% |
28.5 |
% |
34.4 |
% |
||||||||||||
GAAP Operating Income/Margin |
$ |
266,268 |
$ |
356,981 |
$ |
195,045 |
||||||||||||
Percent of Revenue |
27 |
% |
35.6 |
% |
25.3 |
% |
||||||||||||
Acquisition-Related Expenses | 20,410 | 20,039 | 18,902 | |||||||||||||||
Acquisition-Related Transaction Costs | 8,011 | 5,210 | — | |||||||||||||||
Restructuring-Related Expense | 49,463 | — | — | |||||||||||||||
Non-GAAP Operating Income/Margin |
$ |
344,152 |
$ |
382,230 |
$ |
213,947 |
||||||||||||
Percent of Revenue |
35 |
% |
38.1 |
% |
27.8 |
% |
||||||||||||
GAAP Other Expense (Income) |
$ |
32,959 |
$ |
33,547 |
$ |
12,868 |
||||||||||||
Percent of Revenue |
3.3 |
% |
3.3 |
% |
1.7 |
% |
||||||||||||
Amortization of Deferred Financing Costs |
(7,214 |
) |
(13,665 |
) |
— | |||||||||||||
Loss on Extinguishment of Debt | — | — |
(3,289 |
) |
||||||||||||||
Non-GAAP Other Expense |
$ |
25,745 |
$ |
19,882 |
$ |
9,579 |
||||||||||||
Percent of Revenue |
2.6 |
% |
2 |
% |
1.2 |
% |
||||||||||||
GAAP Diluted EPS |
$ |
0.69 |
$ |
0.95 |
$ |
0.52 |
||||||||||||
Acquisition-Related Expenses | 0.07 | 0.06 | 0.06 | |||||||||||||||
Acquisition-Related Transaction Costs | 0.03 | 0.02 | — | |||||||||||||||
Restructuring-Related Expense | 0.16 | — | — | |||||||||||||||
Amortization of Deferred Financing Costs | 0.02 | 0.04 | — | |||||||||||||||
Income Tax Effect of Above Items |
(0.03 |
) |
(0.02 |
) |
— | |||||||||||||
Loss on Extinguishment of Debt |
— |
— | 0.01 | |||||||||||||||
Impact of the Reinstatement of the R&D Tax Credit | — | — |
(0.02 |
) |
||||||||||||||
Non-GAAP Diluted EPS (1) |
$ |
0.94 |
$ |
1.05 |
$ |
0.56 |